Kolinpharma S.p.A.

BIT:KIP Stock Report

Market Cap: €15.9m

Kolinpharma Balance Sheet Health

Financial Health criteria checks 6/6

Kolinpharma has a total shareholder equity of €8.4M and total debt of €8.8M, which brings its debt-to-equity ratio to 105.3%. Its total assets and total liabilities are €22.1M and €13.8M respectively. Kolinpharma's EBIT is €970.9K making its interest coverage ratio 4. It has cash and short-term investments of €9.6M.

Key information

105.3%

Debt to equity ratio

€8.80m

Debt

Interest coverage ratio4x
Cash€9.55m
Equity€8.36m
Total liabilities€13.78m
Total assets€22.14m

Recent financial health updates

We Think Kolinpharma (BIT:KIP) Can Stay On Top Of Its Debt

Jun 08
We Think Kolinpharma (BIT:KIP) Can Stay On Top Of Its Debt

These 4 Measures Indicate That Kolinpharma (BIT:KIP) Is Using Debt Reasonably Well

Nov 22
These 4 Measures Indicate That Kolinpharma (BIT:KIP) Is Using Debt Reasonably Well

Recent updates

Kolinpharma (BIT:KIP) Is Looking To Continue Growing Its Returns On Capital

Jun 17
Kolinpharma (BIT:KIP) Is Looking To Continue Growing Its Returns On Capital

What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?

Dec 01
What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?

An Intrinsic Calculation For Kolinpharma S.p.A. (BIT:KIP) Suggests It's 46% Undervalued

Aug 25
An Intrinsic Calculation For Kolinpharma S.p.A. (BIT:KIP) Suggests It's 46% Undervalued

We Think Kolinpharma (BIT:KIP) Can Stay On Top Of Its Debt

Jun 08
We Think Kolinpharma (BIT:KIP) Can Stay On Top Of Its Debt

Do Kolinpharma's (BIT:KIP) Earnings Warrant Your Attention?

May 21
Do Kolinpharma's (BIT:KIP) Earnings Warrant Your Attention?

Is There An Opportunity With Kolinpharma S.p.A.'s (BIT:KIP) 35% Undervaluation?

May 03
Is There An Opportunity With Kolinpharma S.p.A.'s (BIT:KIP) 35% Undervaluation?

Some Shareholders Feeling Restless Over Kolinpharma S.p.A.'s (BIT:KIP) P/E Ratio

Apr 13
Some Shareholders Feeling Restless Over Kolinpharma S.p.A.'s (BIT:KIP) P/E Ratio

What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?

Feb 20
What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?

Is Weakness In Kolinpharma S.p.A. (BIT:KIP) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Dec 28
Is Weakness In Kolinpharma S.p.A. (BIT:KIP) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

These 4 Measures Indicate That Kolinpharma (BIT:KIP) Is Using Debt Reasonably Well

Nov 22
These 4 Measures Indicate That Kolinpharma (BIT:KIP) Is Using Debt Reasonably Well

Financial Position Analysis

Short Term Liabilities: KIP's short term assets (€15.6M) exceed its short term liabilities (€5.3M).

Long Term Liabilities: KIP's short term assets (€15.6M) exceed its long term liabilities (€8.4M).

Debt to Equity History and Analysis

Debt Level: KIP has more cash than its total debt.

Reducing Debt: KIP's debt to equity ratio has reduced from 201.5% to 105.3% over the past 5 years.

Debt Coverage: KIP's debt is well covered by operating cash flow (31.7%).

Interest Coverage: KIP's interest payments on its debt are well covered by EBIT (4x coverage).

Balance Sheet

Discover healthy companies

7D

1Y

7D

1Y

7D

1Y